Aurinia Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.

About AUPH

Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada. 

CEO
Peter S. Greenleaf
CEOPeter S. Greenleaf
Employees
300
Employees300
Headquarters
Victoria, British Columbia
HeadquartersVictoria, British Columbia
Founded
1993
Founded1993
Employees
300
Employees300

AUPH Key Statistics

Market cap
657.26M
Market cap657.26M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.66M
Average volume1.66M
High today
$4.69
High today$4.69
Low today
$4.46
Low today$4.46
Open price
$4.69
Open price$4.69
Volume
754.99K
Volume754.99K
52 Week high
$24.45
52 Week high$24.45
52 Week low
$4.46
52 Week low$4.46

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
25%
Sell
0%

AUPH Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 28, Pre-Market
ActualExpected Feb 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.